Pregnancy in Generalized Myasthenia Gravis: A Real-World Study of Clinical and Economic Outcomes
This real-world study utilizing U.S. claims data reveals that pregnant women with generalized myasthenia gravis face significantly higher risks of adverse pregnancy outcomes and disease crises while receiving fewer treatments and incurring higher overall healthcare costs compared to their non-pregnant or non-disease counterparts.